Recommendation: Reduce or discontinue bupropion (Wellbutrin) as the most likely culprit for increased anxiety
The most direct approach is to reduce or discontinue bupropion, as it is well-documented to cause or worsen anxiety symptoms, particularly at the 300 mg daily dose this patient is taking. 1, 2, 3
Rationale for Bupropion as the Primary Culprit
Bupropion's mechanism as a norepinephrine and dopamine reuptake inhibitor gives it inherently activating properties that can provoke anxiety, especially at higher doses 1, 2. The evidence shows:
- Bupropion at 300 mg daily is specifically noted to have activating effects and should not be used in agitated patients 1
- Recent systematic reviews confirm bupropion can trigger anxiety symptoms, particularly at higher doses, with its stimulating properties being the mechanism 2, 3
- While bupropion may reduce anxiety in some depressed patients with mild-to-moderate anxiety, it can paradoxically worsen anxiety in others, especially those with pre-existing anxiety disorders 2, 3
Assessment of Other Medications
Buspirone (Buspar): While generally anxiolytic, buspirone can paradoxically cause "jitteriness" with increased anxiety, agitation, restlessness, pressured speech, and racing thoughts in some patients 4. However, this is less common than bupropion-induced anxiety. At 10 mg TID (30 mg total daily), the patient is at a moderate dose (maximum is 60 mg daily) 1.
Cariprazine (Vraylar): At 3 mg daily, this is within the approved range for most indications 5. Recent evidence actually suggests cariprazine may reduce anxiety symptoms in patients with major depressive disorder 6. In bipolar depression trials, common side effects included akathisia and restlessness, but anxiety itself was not prominently reported as worsening 7. Cariprazine is less likely to be the primary cause.
Specific Action Plan
Step 1: Taper and Discontinue Bupropion
- Reduce bupropion from 300 mg to 150 mg daily for 1 week, then discontinue
- Monitor for improvement in anxiety symptoms within 1-2 weeks
- Note: Bupropion discontinuation does not typically require extended tapering for safety, but gradual reduction minimizes potential mood destabilization
Step 2: Monitor Response
- If anxiety improves significantly after bupropion discontinuation, this confirms the diagnosis
- Continue buspirone 10 mg TID and cariprazine 3 mg daily unchanged initially
Step 3: If Anxiety Persists After Bupropion Discontinuation
- Consider reducing or discontinuing buspirone as the next step, given the rare but documented jitteriness syndrome 4
- Taper buspirone by 5 mg every 3-4 days (e.g., 10 mg BID for 4 days, then 5 mg BID for 4 days, then discontinue)
Step 4: Alternative Anxiety Management
If anxiety management is still needed after medication adjustment:
- SSRIs are preferred for anxiety disorders over bupropion 8, 9
- Consider adding an SSRI (e.g., sertraline, escitalopram) if depression or anxiety symptoms require additional pharmacotherapy
- Cognitive behavioral therapy specifically designed for anxiety is evidence-based and should be offered 8, 9
Critical Pitfalls to Avoid
- Do not increase buspirone dose in response to worsening anxiety without first addressing bupropion, as this may worsen paradoxical jitteriness if present
- Do not reduce cariprazine first, as it is the least likely culprit and may actually be providing anxiolytic benefit 6
- Do not add benzodiazepines as a first-line solution without addressing the underlying medication-induced anxiety
- Be aware that cariprazine has a very long half-life (~1 week to decline by 50%), so any dose changes will take weeks to fully manifest 5
Monitoring Parameters
- Assess anxiety symptoms weekly using standardized measures (e.g., GAD-7, HAM-A)
- Monitor for mood destabilization after bupropion discontinuation
- Watch for akathisia versus anxiety (akathisia = motor restlessness with urge to move; anxiety = subjective worry/fear)
- Evaluate within 2-4 weeks after bupropion discontinuation to determine if further medication adjustments are needed